All Articles

The event management giant appoints a new CPO with deep hospitality and tech scaling experience, signaling a major push into practical AI solutions.

Guardian HR and Guardian Payroll Services combine, offering a single-source solution for growing companies navigating complex HR and payroll challenges.

With over $1B in orders, smart aircraft maker AIR is proving demand for personal and cargo eVTOLs is soaring, but regulatory hurdles remain.

Swisslog launches AgileStore, a 4-way roaming pallet shuttle designed to maximize density and adapt to any warehouse, even in deep-freeze conditions.

A deepening helium shortage, driven by Mideast conflict, threatens the global tech industry and sparks a high-stakes hunt for new, stable sources.

With CE Mark approval, Countable Labs brings single-molecule counting PCR to Europe, promising unprecedented precision for gene therapy and diagnostics.

As grid failures and fuel costs rise, one company is betting its future on a new generator ecosystem. But can it deliver on its ambitious promises?

Bessor Minerals abruptly terminates its Jagrite Graphite Project deal, raising questions about its strategy and the volatile critical minerals market.

Facing a cancer diagnosis is overwhelming. Manulife's new Cancer Coach program offers a lifeline with personalized support for daily life and work.

With €10M in new funding, Berlin-based Cellbricks is moving its biofabricated human tissues from lab to preclinical trials, promising a new era for patients.

A new regulated platform from STS Digital, backed by Kraken, unlocks sophisticated investment strategies across 400+ digital assets for institutions.

Two major computer museums join a rental network, giving Hollywood unprecedented access to working vintage hardware for historically accurate productions.

Alongside Google and Nvidia, QuickFi's AI lending platform is revolutionizing the $1.3T equipment finance market. Here's how it's creating a new industry model.

Maze Therapeutics posts positive Phase 2 data for its genetic kidney disease drug, but a sharp stock drop reveals investor concerns in a competitive race.

Following a 40-year career shaping biotech finance, Jessica Chutter's move to PTC's board signals major strategic ambitions for the rare disease firm.

Health Canada greenlights MeMed's rapid diagnostic tool, a major step in the nation's fight against deadly sepsis and growing antimicrobial resistance.

With record sales and a focus on experience over transaction, Shoppes at Four Seasons is cementing Macao's status as the world's top luxury destination.

A new partnership uses advanced AI to find unused grid capacity, slashing data center connection times from years to months and accelerating economic growth.

Chandigarh University makes major leaps in the 2026 QS Rankings, entering the top 300 in key engineering fields and reflecting India's growing global stature.

With a massive new launch, Suave is directly challenging luxury brands by offering high-performance 'dupes' at a fraction of the cost. Is this the new normal?